Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity
| Autor: | Hoagland, Daisy A., Møller, Rasmus, Uhl, Skyler A., Oishi, Kohei, Frere, Justin, Golynker, Ilona, Horiuchi, Shu, Panis, Maryline, Blanco-Melo, Daniel, Sachs, David, Arkun, Knarik, Lim, Jean K., tenOever, Benjamin R. |
|---|---|
| Zdroj: | In Immunity 9 March 2021 54(3):557-570 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|